Source link : https://www.newshealth.biz/health-news/if-cd19-car-t-cell-therapy-fails-in-lymphoma-try-a-cd22-version/
Most though not all patients with large B-cell lymphoma who progressed after CD19-directed chimeric antigen receptor (CAR) T-cell therapy (CAR19) achieved durable responses with a different CAR T-cell treatment, according to results from a dose-finding phase I study. Autologous CD22-directed CAR T-cell therapy (CAR22) in 38 patients failing CAR19 therapy resulted in an overall response […]
Author : News Health
Publish date : 2024-07-10 20:24:42
Copyright for syndicated content belongs to the linked Source.
in Health